Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Crown stays put as $204M Adicon deal falls through
Crown originally planned to transfer all its shares to a subsidiary of Adicon Holdings before the parties mutually agreed to end the pact.
Marissa Russo
Nov 19, 2026 4:55pm
Charles River teams up with Ipsen for toxicology studies
Nov 4, 2026 2:25pm
nPhase rakes in $30M to expand AI-native clinical data platform
Nov 4, 2026 8:21am
IQVIA, Veeva expand partnership for speedier clinical trials
Oct 14, 2026 2:00pm
WCG's AI-powered solution to accelerate clinical trial start-up
Oct 13, 2026 1:29pm
Canadian $5M clinical trial program cuts start-up to 45 days
Sep 29, 2026 3:04pm